956 filings
Page 42 of 48
S-3
ARWR
Arrowhead Pharmaceuticals Inc.
Shelf registration
20 Dec 07
12:00am
10-K
2007 FY
ARWR
Arrowhead Pharmaceuticals Inc.
Annual report
14 Dec 07
12:00am
8-K
ARWR
Arrowhead Pharmaceuticals Inc.
4 Dec 07
Arrowhead Names DR. Christopher Anzalone As Chief Executive
12:00am
8-K
ARWR
Arrowhead Pharmaceuticals Inc.
8 Nov 07
Termination of a Material Definitive Agreement
12:00am
8-K
ARWR
Arrowhead Pharmaceuticals Inc.
6 Nov 07
Arrowhead Subs, Calando and Insert, Appoint
12:00am
8-K
ARWR
Arrowhead Pharmaceuticals Inc.
2 Nov 07
Entry into a Material Definitive Agreement
12:00am
8-K
ARWR
Arrowhead Pharmaceuticals Inc.
30 Oct 07
Entry into a Material Definitive Agreement
12:00am
UPLOAD
ARWR
Arrowhead Pharmaceuticals Inc.
26 Sep 07
Letter from SEC
12:00am
424B3
ARWR
Arrowhead Pharmaceuticals Inc.
20 Sep 07
Prospectus supplement
12:00am
EFFECT
ARWR
Arrowhead Pharmaceuticals Inc.
20 Sep 07
Notice of effectiveness
12:00am
S-3/A
ARWR
Arrowhead Pharmaceuticals Inc.
Shelf registration (amended)
18 Sep 07
12:00am
UPLOAD
ARWR
Arrowhead Pharmaceuticals Inc.
14 Sep 07
Letter from SEC
12:00am
CORRESP
ARWR
Arrowhead Pharmaceuticals Inc.
14 Sep 07
Correspondence with SEC
12:00am
8-K
ARWR
Arrowhead Pharmaceuticals Inc.
13 Sep 07
Termination of a Material Definitive Agreement
12:00am
CORRESP
ARWR
Arrowhead Pharmaceuticals Inc.
24 Aug 07
Correspondence with SEC
12:00am
CORRESP
ARWR
Arrowhead Pharmaceuticals Inc.
17 Aug 07
Correspondence with SEC
12:00am
CORRESP
ARWR
Arrowhead Pharmaceuticals Inc.
9 Aug 07
Correspondence with SEC
12:00am
10-Q
2007 Q3
ARWR
Arrowhead Pharmaceuticals Inc.
Quarterly report
9 Aug 07
12:00am
CORRESP
ARWR
Arrowhead Pharmaceuticals Inc.
6 Jul 07
Correspondence with SEC
12:00am
S-3
ARWR
Arrowhead Pharmaceuticals Inc.
Shelf registration
28 Jun 07
12:00am